 IAL (00 mg/kg of bodyweight), alone treatment group; (c) polymyxin B (0 mg/kg), alone treatment group; and (d) a combination treatment group with IAL (00 mg/kg) and polymyxin B (0 mg/kg). Following simultaneous subcutaneous administration and subsequent administration every 0 hours